Allarity Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 04:36 pm IST
Allarity Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 4.45 million compared to USD 5.04 million a year ago. Basic loss per share from continuing operations was USD 44.8.
For the nine months, net loss was USD 10.18 million compared to USD 13.22 million a year ago. Basic loss per share from continuing operations was USD 387.6.